{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:38:00Z","timestamp":1782225480436,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80483-2","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T15:44:51Z","timestamp":1732203891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7853-7794","authenticated-orcid":false,"given":"Qing-Ao","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-7317","authenticated-orcid":false,"given":"Wen-Jiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4440-5884","authenticated-orcid":false,"given":"Lei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-9701","authenticated-orcid":false,"given":"Xiao-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1123-280X","authenticated-orcid":false,"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"80483_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gines","year":"2021","unstructured":"Gines, P. et al. Liver cirrhosis. Lancet 398, 1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X (2021).","journal-title":"Lancet"},{"key":"80483_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017 (2023).","journal-title":"J. Hepatol."},{"key":"80483_CR3","doi-asserted-by":"publisher","unstructured":"Tapper, E. B. & Parikh, N. D. Diagnosis and management of cirrhosis and its complications. Jama 329 https:\/\/doi.org\/10.1001\/jama.2023.5997 (2023).","DOI":"10.1001\/jama.2023.5997"},{"key":"80483_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis, R. et al. Baveno VII - renewing consensus in portal hypertension. J. Hepatol. 76, 959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022 (2022).","journal-title":"J. Hepatol."},{"key":"80483_CR5","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","volume":"79","author":"DE Kaplan","year":"2024","unstructured":"Kaplan, D. E. et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 79, 1180\u20131211. https:\/\/doi.org\/10.1097\/HEP.0000000000000647 (2024).","journal-title":"Hepatology"},{"key":"80483_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson, N. L. & Anderson, N. G. The human plasma proteome. Mol. Cell. Proteom. 1, 845\u2013867. https:\/\/doi.org\/10.1074\/mcp.R200007-MCP200 (2002).","journal-title":"Mol. Cell. Proteom."},{"key":"80483_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer, P. E. et al. Plasma proteome profiling to assess Human Health and Disease. Cell. Syst. 2, 185\u2013195. https:\/\/doi.org\/10.1016\/j.cels.2016.02.015 (2016).","journal-title":"Cell. Syst."},{"key":"80483_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2022.6051","volume":"159","author":"SS Zhao","year":"2023","unstructured":"Zhao, S. S., Yiu, Z. Z. N., Barton, A. & Bowes, J. Association of lipid-lowering drugs with risk of Psoriasis: a mendelian randomization study. JAMA Dermatol. 159, 275\u2013280. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6051 (2023).","journal-title":"JAMA Dermatol."},{"key":"80483_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w (2021).","journal-title":"Nat. Genet."},{"key":"80483_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6 (2023).","journal-title":"Nature"},{"key":"80483_CR11","doi-asserted-by":"publisher","unstructured":"Bourgault, J. et al. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis. Gastroenterology 164, 953\u2013965 e953, doi: (2023). https:\/\/doi.org\/10.1053\/j.gastro.2023.01.028","DOI":"10.1053\/j.gastro.2023.01.028"},{"key":"80483_CR12","doi-asserted-by":"publisher","unstructured":"Zou, M. & Shao, Z. Proteome-wide mendelian randomization and colocalization analysis identify therapeutic targets for knee and hip osteoarthritis. Biomolecules 14 https:\/\/doi.org\/10.3390\/biom14030355 (2024).","DOI":"10.3390\/biom14030355"},{"key":"80483_CR13","doi-asserted-by":"publisher","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481\u2013487. https:\/\/doi.org\/10.1038\/ng.3538 (2016).","DOI":"10.1038\/ng.3538"},{"key":"80483_CR14","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt, A. F. et al. Genetic drug target validation using mendelian randomisation. Nat. Commun. 11, 3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0 (2020).","journal-title":"Nat. Commun."},{"key":"80483_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9","volume":"15","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Med. 15, 75. https:\/\/doi.org\/10.1186\/s13073-023-01229-9 (2023).","journal-title":"Genome Med."},{"key":"80483_CR16","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng, J. et al. Phenome-wide mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet. 52, 1122\u20131131. https:\/\/doi.org\/10.1038\/s41588-020-0682-6 (2020).","journal-title":"Nat. Genet."},{"key":"80483_CR17","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.xcrm.2023.101174","volume":"4","author":"S Yuan","year":"2023","unstructured":"Yuan, S. et al. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide mendelian randomization and colocalization analyses. Cell. Rep. Med. 4, 101174. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101174 (2023).","journal-title":"Cell. Rep. Med."},{"key":"80483_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8 (2023).","journal-title":"Nature"},{"key":"80483_CR19","doi-asserted-by":"publisher","unstructured":"Karczewski, K. J. et al. Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects. medRxiv https:\/\/doi.org\/10.1101\/2024.03.13.24303864 (2024).","DOI":"10.1101\/2024.03.13.24303864"},{"key":"80483_CR20","doi-asserted-by":"publisher","first-page":"e1008629","DOI":"10.1371\/journal.pgen.1008629","volume":"16","author":"CA Emdin","year":"2020","unstructured":"Emdin, C. A. et al. A missense variant in mitochondrial amidoxime reducing component 1 gene and protection against liver disease. PLoS Genet. 16, e1008629. https:\/\/doi.org\/10.1371\/journal.pgen.1008629 (2020).","journal-title":"PLoS Genet."},{"key":"80483_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0167-9473(01)00097-4","volume":"40","author":"B Li","year":"2002","unstructured":"Li, B. & Martin, E. B. An approximation to the F distribution using the chi-square distribution. Comput. Stat. Data Anal. 40, 21\u201326. https:\/\/doi.org\/10.1016\/s0167-9473(01)00097-4 (2002).","journal-title":"Comput. Stat. Data Anal."},{"key":"80483_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"key":"80483_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"80483_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7 (2018).","journal-title":"Nat. Genet."},{"key":"80483_CR25","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat. Med. 34, 2926\u20132940. https:\/\/doi.org\/10.1002\/sim.6522 (2015).","journal-title":"Stat. Med."},{"key":"80483_CR26","doi-asserted-by":"publisher","first-page":"e1009440","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace, C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 17, e1009440. https:\/\/doi.org\/10.1371\/journal.pgen.1009440 (2021).","journal-title":"PLoS Genet."},{"key":"80483_CR27","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037 (2018).","journal-title":"Nucleic Acids Res."},{"key":"80483_CR28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335\u20131341. https:\/\/doi.org\/10.1038\/s41588-018-0184-y (2018).","journal-title":"Nat. Genet."},{"key":"80483_CR29","doi-asserted-by":"publisher","unstructured":"Hamesch, K. et al. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology 157, 705\u2013719 e718, doi: (2019). https:\/\/doi.org\/10.1053\/j.gastro.2019.05.013","DOI":"10.1053\/j.gastro.2019.05.013"},{"key":"80483_CR30","doi-asserted-by":"publisher","unstructured":"Rabekova, Z. et al. Alpha-1 antitrypsin and Hepatocellular Carcinoma in Liver cirrhosis: SERPINA1 MZ or MS genotype carriage decreases the risk. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms221910560 (2021).","DOI":"10.3390\/ijms221910560"},{"key":"80483_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.15403\/jgld-168","volume":"28","author":"V Basyte-Bacevice","year":"2019","unstructured":"Basyte-Bacevice, V. et al. SERPINA1 and HSD17B13 gene variants in patients with liver fibrosis and cirrhosis. J. Gastrointestin Liver Dis. 28, 297\u2013302. https:\/\/doi.org\/10.15403\/jgld-168 (2019).","journal-title":"J. Gastrointestin Liver Dis."},{"key":"80483_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2205416","volume":"387","author":"P Strnad","year":"2022","unstructured":"Strnad, P. et al. Fazirsiran for Liver Disease Associated with Alpha(1)-Antitrypsin Deficiency. N Engl. J. Med. 387, 514\u2013524. https:\/\/doi.org\/10.1056\/NEJMoa2205416 (2022).","journal-title":"N Engl. J. Med."},{"key":"80483_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0143-4004(77)90002-9","volume":"18","author":"GQ Zhou","year":"1997","unstructured":"Zhou, G. Q. et al. Highly specific monoclonal antibody demonstrates that pregnancy-specific glycoprotein (PSG) is limited to syncytiotrophoblast in human early and term placenta. Placenta 18, 491\u2013501. https:\/\/doi.org\/10.1016\/0143-4004(77)90002-9 (1997).","journal-title":"Placenta"},{"key":"80483_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ijo.2017.248","volume":"42","author":"NM Warrington","year":"2018","unstructured":"Warrington, N. M. et al. Maternal and fetal genetic contribution to gestational weight gain. Int. J. Obes. (Lond). 42, 775\u2013784. https:\/\/doi.org\/10.1038\/ijo.2017.248 (2018).","journal-title":"Int. J. Obes. (Lond)"},{"key":"80483_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12865-020-00385-6","volume":"21","author":"VP Timganova","year":"2020","unstructured":"Timganova, V. P. et al. The effects of human pregnancy-specific beta1-glycoprotein preparation on Th17 polarization of CD4(+) cells and their cytokine profile. BMC Immunol. 21, 56. https:\/\/doi.org\/10.1186\/s12865-020-00385-6 (2020).","journal-title":"BMC Immunol."},{"key":"80483_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2014.08.001","volume":"61","author":"JC Nault","year":"2014","unstructured":"Nault, J. C. & Nahon, P. Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: the NCAN-PNPLA3-lipid connection? J. Hepatol. 61, 971\u2013972. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.001 (2014).","journal-title":"J. Hepatol."},{"key":"80483_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.03.007","author":"D Irala","year":"2024","unstructured":"Irala, D. et al. Astrocyte-secreted neurocan controls inhibitory synapse formation and function. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2024.03.007 (2024).","journal-title":"Neuron"},{"key":"80483_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jhep.2014.06.006","volume":"61","author":"HD Nischalke","year":"2014","unstructured":"Nischalke, H. D. et al. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J. Hepatol. 61, 1073\u20131079. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.006 (2014).","journal-title":"J. Hepatol."},{"key":"80483_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley, R. W. & Rall, S. C. Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507\u2013537. https:\/\/doi.org\/10.1146\/annurev.genom.1.1.507 (2000).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"80483_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.aohep.2019.07.011","volume":"19","author":"JCR Nascimento","year":"2020","unstructured":"Nascimento, J. C. R. et al. Impact of apolipoprotein E genetic polymorphisms on liver disease: an essential review. Ann. Hepatol. 19, 24\u201330. https:\/\/doi.org\/10.1016\/j.aohep.2019.07.011 (2020).","journal-title":"Ann. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80483-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:05:35Z","timestamp":1732205135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80483-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80483-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized publicly available databases, and the data obtained in the original study were approved by ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"28884"}}